FDA Import Refusal 1FX-5690254-8/60002/1D — Caplin Point Laboratories Limited
The FDA refused shipment 1FX-5690254-8/60002/1D from Caplin Point Laboratories Limited (India) on Oct 2, 2026. The refused product falls under Drugs and Biologics — DOXYCYCLINE (TETRACYCLINES). Cited charges: 320,3500,473
Refusal Details
- Date
- Oct 2, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56ECY20 DOXYCYCLINE (TETRACYCLINES)
- Charges
- 320,3500,473